Aripiprazole

CAS 129722-12-9
Back to the Catalog Contact us about this API

General Information

Aripiprazole is a quinoline derivate and atypical antipsychotic agent. Aripiprazole is indicated for managing symptoms of schizophrenia and of acute manic and mixed episodes associated with bipolar I disorders in adults.

About the API

Technology Synthetic
Molecular Formula C23H27Cl2N3O2
Therapeutic category Neurology-Psychiatry
Available formulations Oral Liquid Oral Solid
Regulations CEP Flag CEP EU DMF Flag EU DMF Japan DMF Flag Japan DMF Other Flag Other US DMF Flag US DMF

Updates about Aripiprazole

  • Feb 18, 2016 New JP DMF dated 02/2016 is available.
  • Aug 11, 2020 CEP

Related API products

Dihydroergotoxine Mesylate 8067-24-1 Haloperidol Decanoate 74050-97-8 Desvenlafaxine Succinate 386750-22-7 Fluoxetine HCl 56296-78-7

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.

This site uses cookies (unless you have disabled them) to give you a better and personalized browsing experience and targeted ads.
By continuing your visit on this website, you agree to the use of Cookies on your device. Find out more in our Privacy Policy